Immunic (IMUX) Non Operating Income (2013 - 2026)
Immunic (IMUX) posted Non Operating Income of $1.23 million for Q2 2026, up 366.9% from $263,000 a year earlier and up 89.8% from the prior quarter.
Immunic (IMUX) Non Operating Income (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Immunic was $6.32 million, up 84.2% year-over-year; for FY2025, it came in at $6.06 million.
- Annual Non Operating Income shows a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
- In prior years, Immunic's Non Operating Income was -$2.46 million in FY2024, $5.61 million in FY2023, -$919,000 in FY2022 and -$1.28 million in FY2021.
- Quarterly Non Operating Income has run from a low of -$5.7 million in Q1 2024 to a high of $4.03 million in Q4 2025 over five years.
- On a year-over-year basis, Non Operating Income increased in three of the last seven quarters, with growth averaging 134.5%.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q4 2025, with growth of 783.1%; the weakest was Q4 2021, with a decline of 82.3%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $647,000 (Q1 2026), $4.03 million (Q4 2025) and $414,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.89 Bn | 1,138.48 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 648.35 Bn | 568.21 Bn | 17.30 Bn | - |
| 3 | AbbVie | 504.24 Bn | 477.35 Bn | 12.70 Bn | - |
| 4 | Merck | 365.96 Bn | 320.33 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 303.28 Bn | 267.27 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.76 Bn | 198.16 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 194.96 Bn | 169.16 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 172.99 Bn | 119.64 Bn | 10.94 Bn | - |
| 10 | Immunic | 308.23 Mn | -84.12 Mn | - | 1.23 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Mn |
| Mar 31, 2026 | 647,000.00 |
| Dec 31, 2025 | 4.03 Mn |
| Sep 30, 2025 | 414,000.00 |
| Jun 30, 2025 | 263,000.00 |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | -5.70 Mn |
| Dec 31, 2023 | 1.81 Mn |
| Sep 30, 2023 | 801,000.00 |
| Jun 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | 853,000.00 |
| Sep 30, 2022 | -1.11 Mn |
| Jun 30, 2022 | -1.29 Mn |
| Mar 31, 2022 | 627,000.00 |
| Dec 31, 2021 | 536,000.00 |
| Sep 30, 2021 | -905,000.00 |
Immunic Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=IMUX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "IMUX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=IMUX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();